Actively Recruiting
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
Led by San Raffaele University · Updated on 2026-04-24
2300
Participants Needed
8
Research Sites
630 weeks
Total Duration
On this page
Sponsors
S
San Raffaele University
Lead Sponsor
F
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
Collaborating Sponsor
AI-Summary
What this Trial Is About
An increase in early-onset colorectal cancers (eoCRC), defined as a CRC before 50 years, is confirmed globally. CRC pathogenesis has been associated with several risk factors (family history, germline pathogenic variants, obesity, alcohol, physical activity, red meat, and a Western diet). Design: an international, multicenter, retrospective case-control study of prospectively enrolled patients; low-risk intervention study as it will perform a fecal occult blood test Endpoint: predictive power of a semi-quantitative food frequency questionnaire (SQFFQ) developed for eoCRC. Cases: Patients with a recent diagnosis of eoCRC (within 2 years from enrollment). Controls: matched by age (matching range ± 5 years) and sex. Healthy volunteers will be mainly enrolled among workers within the participating hospital center. The enrolled healthy volunteers will perform a fecal occult blood test. Variables of interest: age, sex, ethnicity, BMI at the time of eoCRC diagnosis and at 18 years old, country, tobacco smoking at the time of eoCRC diagnosis and at 18 years old, sitting time, TV-viewing time, moderate-to-vigorous physical activity (MVPA), waist circumference (cm), home blood pressure levels (mmHg), fasting blood glucose (mg/dl), regular consumption of aspirin/NSAID, calcium and folate supplements, oral contraceptive agents, post-menopausal hormones and years of consumptions, if the filled questionnaire reflects diet for the last 5-10 years before. Cases only: date of eoCRC diagnosis, symptoms at diagnosis, eoCRC localization, eoCRC stage, histological diagnosis, type of surgery, and date (if performed), chemotherapy and radiotherapy (if performed), vital status and duration of follow-up, family history of CRC and other cancers (uterus, ovary, stomach, small intestine, urinary tract/bladder/kidney, bile ducts, brain, pancreas, skin tumors), type of germline pathogenetic variant (if performed). Before the case-control study, three non-consecutive 24-hour Dietary Recalls (24hDRs) will validate the SQFFQ. The SQFFQ will be administered to the validation study group during three non-consecutive calls, including one non-weekday (30-minute 24-h-recall computer-aided personal interview). Primary Objective To measure the relative risk of specific dietary and lifestyle factors (smoking habit, alcohol intake, physical activity) for early-onset colorectal cancer in countries where eoCRC incidence is increasing versus stable/decreasing
CONDITIONS
Official Title
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All sexes eligible
- For cases: early-onset colorectal cancer diagnosed between 18 and 49 years and confirmed by histology
- For controls: no past or present history of cancer
- For controls: negative fecal occult blood test or negative colonoscopy
You will not qualify if you...
- Colorectal cancer diagnosed at 50 years or older
- Diseases that can change diet, such as celiac disease or diabetes
- Diseases that increase risk of early-onset colorectal cancer, like inflammatory bowel disease or past pelvic irradiation
- Unable to give written consent or complete the electronic questionnaire
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 8 locations
1
Department of Medicine-Gastroenterology, Denver Veterans Affairs Medical Center, University of Colorado Hospital
Denver, Colorado, United States, 80045
Actively Recruiting
2
Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine University of Chicago Medicine
Chicago, Illinois, United States, 60637
Actively Recruiting
3
Department of Gastrointestinal Surgery, Helsinki University Hospital
Helsinki, Finland
Actively Recruiting
4
Department of General, Visceral and Transplant Surgery, Hospital of the University of Munich (LMU)
Munich, Germany
Actively Recruiting
5
Gabriela Moslein
Wuppertal, Germany
Actively Recruiting
6
Prof Giulia Martina Cavestro, MD PhD
Milan, Lombardy, Italy, 20132
Actively Recruiting
7
Division of Cancer Medicine, Oslo University Hospital (OUS), Institute for Cancer Genetics and Informatics Norwegian Radium Hospital
Oslo, Norway
Actively Recruiting
8
Department of Gastroenterology, Hospital Clínic de Barcelona, University of Barcelona
Barcelona, Spain
Actively Recruiting
Research Team
G
Giulia Martina Cavestro, MD PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here